Kidney failure, a silent killer, often goes unnoticed as the body adapts, masking symptoms like fatigue and swelling. The kidneys don’t cry for help.

Long-term exposure to water contaminants, even below the regulatory limits, significantly increases the risk of chronic ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

SGLT2 inhibitor use may help stabilize eGFR levels for patients with autosomal dominant polycystic kidney disease and type 2 diabetes, according to study data.“Given its unique pathophysiology, ...

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with AMI.

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Patients with COVID-19 who required hospitalisation had a more than sevenfold higher risk for kidney failure than individuals without the condition, with this elevated risk persisting beyond 180 days.

Chronic kidney disease (CKD) is the commonest kidney disease that is diagnosed. It basically means that the kidney is functioning less than optimal for a duration of more than three months.

State government has announced that the kidney disease-prone A. (Atlapragada) Kondur area will be supplied safe drinking water from the Krishna River within the next six weeks under the Jal Jeevan ...